23andme glp 1 A large study of customers found variants in two genes that play a role in weight loss, and nausea and vomiting. (📸: Milatas/Getty Images) #science #genetics #glp1 #health #medicine #weightloss GLP-1 Articles | 23andMe Blog

GLP-1 medications like semaglutide and tirzepatide are FDA-approved treatments that support sustainable weight loss by regulating appetite, improving insulin sensitivity, and addressing metabolic challenges.

Our medical weight loss program utilizes cutting-edge treatments like GLP-1 to help you achieve your goals safely and effectively

Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity

Roughly 1 in 10 people carry a genetic variant that meaningfully blunts GLP-1 response

These different uses have different economic consequences, Donovan explains: Obese patients who use GLP-1s should become more productive employees, Donovan expects less subject to prejudice, and less likely to be absent from work